Literature DB >> 8813375

Norepinephrine transmitter metabolite is a selective cell death messenger in differentiated rat pheochromocytoma cells.

W J Burke1, C A Schmitt, K N Gillespie, S W Li.   

Abstract

3,4-Dihydroxyphenylglycolaldehyde (DOPEGAL) is the monoamine oxidase A (MAO-A) metabolite of norepinephrine (NE) and epinephrine (Epi). Oxidative metabolites of amines are predicted toxins. In this study we determine the toxicity of DOPEGAL, its tautomer 2',3,4-trihydroxyacetophenone (THAP) as well as NE, Epi and their oxidative and methylated metabolites in cultures of differentiated PC-12 cells. At 59.5 microM DOPEGAL, THAP and Epi, but not NE or other NE or Epi metabolites decreased PC-12 cells by 43.8%, 26.7% and 16.8% respectively. DOPEGAL toxicity was concentration and time dependent. Possible implications for degenerative diseases are discussed.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8813375     DOI: 10.1016/0006-8993(96)00129-1

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  7 in total

1.  Norepinephrine metabolite DOPEGAL activates AEP and pathological Tau aggregation in locus coeruleus.

Authors:  Seong Su Kang; Xia Liu; Eun Hee Ahn; Jie Xiang; Fredric P Manfredsson; Xifei Yang; Hongbo R Luo; L Cameron Liles; David Weinshenker; Keqiang Ye
Journal:  J Clin Invest       Date:  2020-01-02       Impact factor: 14.808

Review 2.  Changes in the physiological roles of neurotransmitters during individual development.

Authors:  G A Buznikov; J M Lauder
Journal:  Neurosci Behav Physiol       Date:  1999 Jan-Feb

3.  ApoE4 inhibition of VMAT2 in the locus coeruleus exacerbates Tau pathology in Alzheimer's disease.

Authors:  Seong Su Kang; Eun Hee Ahn; Xia Liu; Matthew Bryson; Gary W Miller; David Weinshenker; Keqiang Ye
Journal:  Acta Neuropathol       Date:  2021-04-25       Impact factor: 15.887

4.  Tau modification by the norepinephrine metabolite DOPEGAL stimulates its pathology and propagation.

Authors:  Seong Su Kang; Lanxia Meng; Xingyu Zhang; Zhiping Wu; Ariana Mancieri; Boer Xie; Xia Liu; David Weinshenker; Junmin Peng; Zhentao Zhang; Keqiang Ye
Journal:  Nat Struct Mol Biol       Date:  2022-03-24       Impact factor: 18.361

5.  Oxidative Transformations of 3,4-Dihydroxyphenylacetaldehyde Generate Potential Reactive Intermediates as Causative Agents for Its Neurotoxicity.

Authors:  Shosuke Ito; Hitomi Tanaka; Makoto Ojika; Kazumasa Wakamatsu; Manickam Sugumaran
Journal:  Int J Mol Sci       Date:  2021-10-29       Impact factor: 5.923

6.  Effect of ALDH2 on Sleep Disturbances in Patients with Parkinson's Disease.

Authors:  Chia-Yen Lin; Rwei-Ling Yu; Ruey-Meei Wu; Chun-Hsiang Tan
Journal:  Sci Rep       Date:  2019-12-12       Impact factor: 4.379

Review 7.  Delta-secretase cleavage of Tau mediates its pathology and propagation in Alzheimer's disease.

Authors:  Seong Su Kang; Eun Hee Ahn; Keqiang Ye
Journal:  Exp Mol Med       Date:  2020-08-28       Impact factor: 8.718

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.